These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7199118)

  • 1. Effects of prolonged chemical treatment with cyclophosphamide and 6-mercaptopurine in the dominant lethal test system.
    Moreland FM; Sheu CW; Springer JA; Green S
    Mutat Res; 1981 Oct; 90(2):193-9. PubMed ID: 7199118
    [No Abstract]   [Full Text] [Related]  

  • 2. 6-mercaptopurine, an inducer of cytogenetic and dominant-lethal effects in premeiotic and early meiotic germ cells of male mice.
    Generoso WM; Preston RJ; Brewen JG
    Mutat Res; 1975 Jun; 28(3):437-47. PubMed ID: 1134513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rodent dominant lethal assay: a proposed format for data presentation that alerts to pseudo-dominant lethal effects.
    Ashby J; Clapp MJ
    Mutat Res; 1995 Aug; 330(1-2):209-18. PubMed ID: 7623866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dominant lethal test in mice with 6-mercaptopurine.
    Schencking MS; Frohberg H
    Arch Toxicol; 1975 Sep; 34(1):71-5. PubMed ID: 1242638
    [No Abstract]   [Full Text] [Related]  

  • 5. Morphological and cytogenetic studies of dominant lethality induced by mitomycin C and cyclophosphamide in female germ cells. The use of Robertsonian translocations as a 'marker system' to identify the zygote pronuclei.
    Jacquet P; Pire P
    Mutat Res; 1984 Sep; 128(2):181-94. PubMed ID: 6433189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of results from a collaborative study of the dominant lethal assay.
    James DA; Smith DM
    Mutat Res; 1982 Aug; 97(4):303-14. PubMed ID: 7121502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimutagenic effects on male germ cells of mice.
    Renner HW; Knoll M
    Mutat Res; 1984; 140(2-3):127-9. PubMed ID: 6749171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dynamics of dominant lethal mutations in male mice exposed to cyclophosphamide in drinking water for different periods of time].
    Zhurkov VS; Shram RIa
    Genetika; 1978 May; 14(5):824-8. PubMed ID: 669258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of specific-locus and dominant lethal mutations in male mice by trophosphamide.
    Ehling UH; Neuhäuser-Klaus A
    Mutat Res; 1994 May; 307(1):229-36. PubMed ID: 7513801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cyclophosphamide, 6-mercaptopurine or methotrexate on the Furth rat leukaemia.
    Green HN; Shortridge D
    Nature; 1967 Jul; 215(5096):71-2. PubMed ID: 6053409
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship between acute and chronic exposures in mutagenicity studies in mice.
    Srám RJ
    Mutat Res; 1976 Nov; 41(1 spel. no):25-42. PubMed ID: 64927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of alternative distributions of postimplantation death in the dominant lethal assay.
    Smith DM; James DA
    Mutat Res; 1984 Sep; 128(2):195-206. PubMed ID: 6472312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative effectiveness of different tests to determine the mutagenicity of certain factors in mammals. II. Frequency of anomalous sperm head in mice exposed to different factors].
    Pomerantseva MD; Ramaĭia LK; Vilkina GA
    Genetika; 1980; 16(8):1397-1403. PubMed ID: 7193160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A guide for mutagenicity testing using the dominant lethal assay.
    Green S; Lavappa KS; Manandhar M; Sheu CJ; Whorton E; Springer JA
    Mutat Res; 1987 Oct; 189(2):167-74. PubMed ID: 3657832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between early deaths and implants in control and mutagen-treated CD-1 mice in dominant lethal assays.
    Anderson D; McGregor DB; Weight TM
    Mutat Res; 1981 Apr; 81(2):187-96. PubMed ID: 7195460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of the dominant lethal test in the freshwater mollusk Biomphalaria glabrata (Say, 1818).
    Nakano E; Watanabe LC; Ohlweiler FP; Pereira CA; Kawano T
    Mutat Res; 2003 Apr; 536(1-2):145-54. PubMed ID: 12694755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mutagenic hazard of the parenteral body uptake of ethylene oxide in mammals].
    Liarskiĭ PP; Iurchenko VV; Zhurkov VS; Gleĭberman SE
    Gig Sanit; 1983 Jan; (1):23-6. PubMed ID: 6826062
    [No Abstract]   [Full Text] [Related]  

  • 18. Mutagenicity tests with mebendazole in the mouse.
    Mutat Res; 1974 Oct; 26(5):427-30. PubMed ID: 4414746
    [No Abstract]   [Full Text] [Related]  

  • 19. Study of possible mutagenicity of bucloxic acid (804 CB).
    Mazué G; Vindel JA; Landsmann F; Brunaud M
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1422-5. PubMed ID: 4614818
    [No Abstract]   [Full Text] [Related]  

  • 20. Towards an improved micronucleus test: studies on 3 model agents, mitomycin C, cyclophosphamide and dimethylbenzanthracene.
    Salamone M; Heddle J; Stuart E; Katz M
    Mutat Res; 1980 Oct; 74(5):347-56. PubMed ID: 6782470
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.